manidipine and interleukin-8
manidipine has been researched along with interleukin-8 in 2 studies
Research
Studies (2)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Block, LH; Nauck, M; Rödler, S; Roth, M; Tamm, M | 1 |
| Bernini, F; Costa, S; Cremonesi, G; Pedrelli, M; Zimetti, F | 1 |
Other Studies
2 other study(ies) available for manidipine and interleukin-8
| Article | Year |
|---|---|
Ca(2+)-channel blockers modulate the expression of interleukin-6 and interleukin-8 genes in human vascular smooth muscle cells.
Topics: Adrenergic beta-Antagonists; Amlodipine; Calcium Channel Blockers; Calcium Channels; Calcium Channels, L-Type; Cells, Cultured; Dihydropyridines; Diuretics; Felodipine; Fibroblasts; Furosemide; Gene Expression Regulation; Humans; Interleukin-6; Interleukin-8; Isradipine; Lung; Muscle Proteins; Muscle, Smooth, Vascular; Nitrobenzenes; Piperazines; Propranolol; Transcription, Genetic | 1995 |
Manidipine reduces pro-inflammatory cytokines secretion in human endothelial cells and macrophages.
Topics: Calcium Channel Blockers; Cell Line; Cell Survival; Cells, Cultured; Dihydropyridines; Endothelial Cells; Humans; Interleukin-6; Interleukin-8; Macrophages; NF-kappa B; Nitrobenzenes; Piperazines; Tumor Necrosis Factor-alpha | 2010 |